Excellerant, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXCL research report →
Companyexcellerant.vc
Excellerant, Inc. , a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company intends to offer consulting services in the field of traditional and alternative medicine, and medical technologies; for customers to choose a clinic for treatment, as well as arrange the itinerary by building a route, which includes clinics, hospitals, and other medical institutions; and providing guide services to potential clients.
- CEO
- Roman Kopinski
- IPO
- 2021
- Employees
- 1
- HQ
- Brussels, BE
Price Chart
Valuation
- Market Cap
- $1.13K
- P/E
- -0.08
- P/S
- 0.00
- P/B
- -0.06
- EV/EBITDA
- 0.50
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 106.26%
- ROIC
- 231.85%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-13,800 · 36.82%
- EPS
- $-0.01 · -63.83%
- Op Income
- $-13,800
- FCF YoY
- -141.77%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.85
- Avg Volume
- 7.952
Get TickerSpark's AI analysis on EXCL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EXCL Coverage
We haven't published any research on EXCL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EXCL Report →